French startup Nūmi (previously MUMilk ), a biotech pioneering the production of cell-cultured breast milk, secured €3 million in pre-seed funding .

© Nūmi

Cultivated, Cell-Cultured & Biotechnology

Cow’s Milk Alternative for Infants: Nūmi Raises €3M to Develop Cell-Cultivated Breast Milk

French startup Nūmi (previously MUMilk), a biotech pioneering the production of cell-cultured breast milk, announces it has raised €3 million in pre-seed funding from a group of investors including Heartcore Capital, HCVC, Financière Saint-James, Kima Ventures, and Kost Capital. The new capital will support the expansion of the company’s scientific teams, facilitate its next phase of R&D, and progress toward marketing the company and its products. Nūmi, setting out to revolutionize the infant nutrition industry, states that this achievement represents a significant milestone in furthering its mission to redefine infant health by providing an alternative to cow’s milk for women unable or unwilling to breastfeed. “I am extremely proud to conclude this first round of financing, which marks a crucial stage in our development for …

more

Wilk team

©Wilk

Cultivated, Cell-Cultured & Biotechnology

Coca-Cola Backed Wilk Receives US Patent Approval to “Revolutionize” Dairy Industry

Israel’s Wilk, a publicly-traded company on the Tel Aviv Stock Exchange under the ticker symbol WILK, develops industrial processes for producing cultivated human and animal milk from milk-producing mammary cells. The company announces it has now received US patent approval. “This will help to further establish our reputation as a leader in the field of cell-based milk production, while bringing us one step closer to the ultimate goal of revolutionizing the dairy industry.” Previously known as Biomilk, the company received $2 million last summer from Coca-Cola Israel, operating as The Central Bottling Company (CBC) – the exclusive Israeli franchise of Coca-Cola. Wilk reveals it has received patent approval for Methods and Systems for in-Vitro Milk Production from the US Patent and Trademark Office, making it …

more

Advanced Protein Technologies

©Advanced Protein Technologies

Investments & Finance

Roquette Backs South Korea’s Advanced Protein Technologies in €15M Funding for Human Milk Prebiotics 

South Korean biotech company Advanced Protein Technologies (APTech), has secured a new funding round totaling €15 million for its development of Human Milk Oligosaccharides (HMOs). The funding included backing from French ingredient giant Roquette’s investment arm.   A producer of new prebiotics, APTech is developing technology for the production of more HMOs found in higher concentrations than in human milk. Leading international food companies include HMOs in their infant formula and baby food owing to its various proven direct health benefits, with the HMO annual market potential currently forecast at $1.5bn for 2026.  The equity was raised from new and existing investors including Roquette Ventures and will be used to commercialize APTech’s HMOs which have recently been authorized by the US Food and Drug Administration as …

more

BIOMILQ_Michelle_Egger_Leila_Strickland3

BIOMILQ founders Michelle Egger & Leila Strickland, image supplied

Cultivated, Cell-Cultured & Biotechnology

$21M Series A For BIOMILQ’s “Human Milk For Babies” Means Mothers Won’t Have to Rely On Dairy Products

US biotech company BIOMILQ, which produced human breast milk outside of the body for the first time this June, has raised $21 million in a Series A funding round. BIOMILQ’s breast milk will provide a much-needed solution for parents who wish to breastfeed but aren’t able to. Conventional infant formulas are usually dairy-based, and as such not suitable for mothers who choose not to consume animal flesh or secretions. Additionally, dairy options struggle to match the nutritional profile of human breast milk. The round was led by Novo Holdings and Breakthrough Energy Ventures, with support from others including Blue Horizon and Spero Ventures. The new Series A funding will allow the company to optimise the production process, launching commercially within the next four years. After …

more

Turtletree Sacramento

©TurtleTree

Cultivated, Cell-Cultured & Biotechnology

TurtleTree’s New Sacramento R&D Facility Set to Bring Cell-Based Milk & Dairy to Consumers

TurtleTree, the Singapore based producer of the world’s first human breast milk created with cellular technology, has officially announced the opening of a new R&D facility in West Sacramento, which will develop precision fermentation technology, marking a “significant stride towards the production of consumer-ready milk and dairy” according to the company. The company, whose recently launched subsidiary Turtle Tree Science is working to bring cell-based meat and dairy products to market, produces milk ingredients such as lactoferrin – a protein usually derived from cow’s milk which the team has optimised for humans from the blueprint of human breast milk. Turtletree announced this June it was preparing to commercialise the lactoferrin as its first product to market. The new facility is set to create around 40 …

more

Singapore/ US based TurtleTree ready to commercialize Human Lactoferrin as first major product

©TurtleTree Labs

Cultivated, Cell-Cultured & Biotechnology

TurtleTree Labs Prepares to Commercialise its First Human Cell-Based Milk Product

Singapore’s cell-based milk pioneers TurtleTree Labs has announced it is preparing to commercially launch its first product – lactoferrin – a protein usually derived from cow’s milk which the team has optimised for humans from the blueprint of human breast milk and is making it available to all. “We have seen tremendous interest from global partners in our portfolio of human and cow’s milk products” In addition to its protective role, lactoferrin plays an important role in brain development and inflammatory responses. While it will be a few years before cell-based whole milk meets regulatory requirements, TurtleTree has decided to go commercial by moving deeper into the realm of milk components. In December of last year, TurtleTree announced an oversubscribed $6.2 million Pre-A funding round …

more

Co-founders Fengru Lin & Max Rye, TurtleTree Labs

Co-founders Fengru Lin & Max Rye, TurtleTree Labs

Company News

TurtleTree Labs Raises $6.2M From Stellar Lineup of Investors

More great foodtech news from Singapore as TurtleTree Labs, creators of real dairy milk through cell technology, announces an oversubscribed $6.2 million Pre-A funding round of new and existing global investors. It is also announced that the “vegan prince”, HRH Prince Khaled bin Alwaleed bin Talal Al Saud will join as Advisor.

more